Delivery Order SPE2DR25D1205-SPE2DR26F1BX9

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 12, 2026, for Barhemsys 10 mg/4 mL vials, with a ceiling value of $1,432.08.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of February 13, 2026. No set-aside was used.</p>

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Barhemsys 10 mg/4 ml vials valued at $1,011.46 under a firm fixed-price contract type. The delivery order was awarded on December 18, 2025, with an ultimate completion date of December 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was not set aside for any specific business category and was competitively awarded. This delivery order...

The Defense Logistics Agency awarded a $1,078.30 delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 13, 2026, for the supply of Barhemsys 5 mg/2 ml vials with a completion date of January 14, 2026. This firm fixed-price contract represents a non-set-aside award issued under open competition. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. Barhemsys is a prescription medication used for...

The Defense Logistics Agency awarded a delivery order valued at $2,786.95 to AmerisourceBergen Drug Corp for Barhemsys 5 mg/2 ml vials on October 30, 2025, with completion expected by October 31, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal vendor, serves the Defense Logistics...

The Defense Logistics Agency awarded a $1,169.78 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Barhemsys 5 mg/2 ml vial (2 ml units). This firm fixed-price, non-set-aside contract is scheduled for completion by December 4, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the Defense...

The Defense Logistics Agency awarded a delivery order valued at $4,813.91 to AmerisourceBergen Drug Corp for BARHEMSYS 10 mg/4 mL vials on January 21, 2026, with completion scheduled for January 22, 2026. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor...

The Defense Logistics Agency awarded a $2,554.97 delivery order to AmerisourceBergen Drug Corp for BARHEMSYS 10 mg/4 ml vials on October 17, 2025, with an ultimate completion date of October 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. BARHEMSYS (amisulpride) is an atypical antipsychotic medication used in clinical settings to treat...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of BARHEMSYS 10 mg/4 ml vials with a ceiling value of $1,285.79. This competitively awarded, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract carries an ultimate completion date...

<p>The Defense Logistics Agency issued a $3,506.40 delivery order to Amerisourcebergen Drug Corp on February 18, 2026, for Hemabate 250 mcg/ml ampule pharmaceutical product.</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of February 19, 2026, and is priced on a firm fixed-price basis.</p>

<p>The Defense Logistics Agency issued a $2,604.64 delivery order to Amerisourcebergen Drug Corp on February 12, 2026, for phenobarbital 130 mg/ml vial supply, with ultimate completion on February 13, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside applied.</p>